Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS

by Van Gorp Toon, Cadron Isabelle, Daemen Anneleen, De Moor Bart, Waelkens Etienne, Vergote Ignace
Published 2012-06-01

Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation

by Amant Frederic, Engelen Kristof, Pochet Nathalie, Van Gorp Toon, De Smet Frank, Gevaert Olivier, De Moor Bart, Timmerman Dirk, Vergote Ignace
Published 2008-01-01

Sentinel node in ovarian cancer: study protocol for a phase 1 study

by Kleppe Marjolein, Van Gorp Toon, Slangen Brigitte FM, Kruse Arnold J, Brans Boudewijn, Pooters Ivo NA, Van de Vijver Koen K, Kruitwagen Roy FPM
Published 2013-02-01

Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium

by Aust Stefanie, Bachmayr-Heyda Anna, Pateisky Petra, Tong Dan, Darb-Esfahani Silvia, Denkert Carsten, Chekerov Radoslav, Sehouli Jalid, Mahner Sven, Van Gorp Toon, Vergote Ignace, Speiser Paul, Horvat Reinhard, Zeillinger Robert, Pils Dietmar
Published 2012-09-01

Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study

by Rutten Marianne J, Gaarenstroom Katja N, Van Gorp Toon, van Meurs Hannah S, Arts Henriette JG, Bossuyt Patrick M, Ter Brugge Henk G, Hermans Ralph HM, Opmeer Brent C, Pijnenborg Johanna MA, Schreuder Henk WR, Schutter Eltjo MJ, Spijkerboer Anje M, Wensveen Celesta WM, Zusterzeel Petra, Mol Ben Willem J, Kenter Gemma G, Buist Marrije R
Published 2012-01-01